Provides a global network for sharing and management of genomic data and tools to accelerate genomics.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
DNAnexus provides a global network for sharing and management of genomic data and tools to accelerate genomics. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab.
DNAnexus Funding
Sign up to gain insights into DNAnexus funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series I | Mar 03, 2022 | 200M | ||
| Series H | Mar 15, 2021 | 32M | ||
| Series G | Jun 05, 2020 | 16M | ||
| Series F-2 | Feb 06, 2019 | 14M | ||
| Series F-1 | Sep 01, 2017 | 31M | ||
| Series E | Jan 11, 2017 | 22M | ||
| Series D | Apr 16, 2015 | 15M | ||
| Series C | Dec 20, 2013 | 15M | ||
| Series B | Mar 31, 2011 | 15M | ||
| Series A | May 13, 2009 | 2M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
DNAnexus Management Team
Investors
Blackstone Growth (BXG)
Capital Partners, Inc.
Claremont Creek Ventures
Felicis Ventures
First Round Capital
Foresite Capital
Foresite Capital Management LLC
Google Ventures
Innovatus Capital Partners, LLC
K9 Ventures LP
M12; FKA: Microsoft Ventures
MidCap Financial
Northpond Ventures LLC
Perceptive Advisors, LLC
Regeneron Pharmaceuticals, Inc.
SoftTech Ventures
Tarrant Capital IP LLC
TPG Biotech
TPG Capital LP
WuXi NextCODE
WuXi PharmaTech
DNAnexus Valuations & Financials
View real-time NPM data on DNAnexus stock including daily DNAnexus stock price estimates, valuation history, and historical share price information. Access DNAnexus financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track DNAnexus pricing across six independent market signals. Looking for private company due diligence data sources on DNAnexus? Get in touch to learn more.
Similar Companies
like DNAnexus
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
HundredX
Enterprise Software
A data analytics company that delivers real-time customer insights to inform strategic decisions and enhance financial outcomes.
Sourcetable
Enterprise Software
Spreadsheet platform combining data warehousing, live sync, and traditional features like charting, pivots, and real-time collaboration.
Flux
Enterprise Software
Enhances hardware design by offering shared tools that simplify circuit layout, review, and project management.
ClientSuccess
Enterprise Software
Helps teams guide customer journeys and improve retention using analytics, engagement tracking, and lifecycle tools.
Lightyear AI
Enterprise Software
Automates telecom service lifecycles that unify procurement, inventory, and billing into a streamlined, cost-savvy digital system.
Fireproof
Enterprise Software
Support developers who build data-driven apps by offering a browser-based database that syncs live, works offline, and integrates easily.
Bambee
Enterprise Software
Provides dedicated HR management services and compliance solutions for small businesses, handling policies and employee relations.
Itilite
Enterprise Software
All-in-one platform streamlines corporate travel booking, expense management and card services to simplify business travel and reimbursement.
FAQ
We have answers
DNAnexus stock does not trade on public stock exchanges. DNAnexus stock is considered a private security and you need to be an accredited investor to trade shares. To invest in DNAnexus stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
DNAnexus Stock does not trade on public stock exchanges. In order to sell DNAnexus shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
DNAnexus does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view DNAnexus share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for DNAnexus stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell DNAnexus stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in DNAnexus stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
DNAnexus is a private company and has not had an IPO. There is currently no DNAnexus IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to DNAnexus IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
